期刊文献+

Fontan术后血浆内皮素-1和肾上腺髓质素的改变研究 被引量:3

Change of Endothelin-1 and Adrenomedullin after the Fontan operation
下载PDF
导出
摘要 目的 探讨血浆内皮素-1(ET-1)和肾上腺髓质素(AM)在Fontan手术前后的变化情况及相互关系.方法 随机选择2012年1~6月武汉亚洲心脏病医院行Fontan手术的患儿8例,为Fontan组;另随机选择8例先天性心脏病患儿行双心室修复,为对照组.两组患者术前经超声心动图或心导管检查都排除了继发性肺动脉高压.于体外循环(CPB)前即刻采5ml静脉血测定血浆ET-1和AM水平.术后即刻,术后6h、24h采静脉血测定血浆ET-1和AM的水平.结果 两组血浆ET-1水平于CPB后均升高,在CPB后6h达到峰值,CPB后24h减少.在CPB后6h及24 h,Fontan组与对照组相比,血浆ET-1水平呈显著高值[(8.41±2.28)pg/ml比(5.30±1.17)pg/ml,P=0.004;(8.40±2.28)pg/ml比(2.45±0.70)pg/ml,P=0.031],差异有统计学意义.两组血浆AM水平在CPB后均立即增加,在CPB 6 h后对照组达到峰值.CBP后6h,Fontan组血浆AM水平升高的程度显著低于对照组[(81.50±37.93)pg/ml比(221.00±59.71)pg/ml,P=0.045],24h迅速恢复到CPB前基线水平,与对照组相比表现为显著低值[(72.62±25.07)pg/ml比(174.75±73.33)pg/ml,P=0.000],差异有统计学意义.结论 Fontan手术体外循环后患者ET-1表现出显性效应,可能在Fontan手术后的血管收缩机制中起重要作用.AM参与了Fontan手术后保护机制. Objective To investigate the time course and mutual relationships of Endothelin-1 and Adrenomedullin before and after the Fontan operation. Methods Eight patients who had Fontan operation in Wuhan Asia Heart Hospital(2012.01-2012.06) were randomly selected into the Fontan group, and another 8 children with congenital heart diseases who had biventrieular repair were set to the control group. Secondary pulmonary hypertension had been excluded by echoeardiography or cardiac catheterization in both two groups. Immediately before cardiopulmonary bypass (CPB), 5 ml of venous blood was drawn to measure the plasma ET- 1 and AM levels. Plasma ET-1 and adrenomedullin levels were also measured in both groups immediately after operation, and 6 and 24 hours after operation. Results The plasma ET-1 levels increased after CPB, peaked at 6 hours after CPB, and decreased 24 hours after CPB in both groups. However, the plasma ET-1 level in the Fontan group showed a significantly higher value compared with the control group at 6 and 24 hours after CPB [ (8.41±2.28)pg/ml vs (5.30±1.17)pg/ml, P=0.004], [(8.40±2.28)pg/ml vs (2.45±0.70)pg/ml, P=0.031 ]. The difference are statistically significant. The plasma AM levels increased immediately after CPB in both groups and continued to increase after CPB, peaking at 6 hours after CPB. In the Fontan group, the plasma AM level showed significantly lower values compared with the control group at 6 hours after CPB [(81.50±37.93)pg/ml vs (221.00±59.71)pg/ml, P= 0.045] and returned to the baseline level at 24 hours after CPB rapidly[(72.62±25.07)pg/ml vs (174.75±73.33) pg/ml, P=0.000]. The difference also shows statistically significant. Conclusion ET-1 shows dominant effects after cardiopuhnonary bypass in the Fontan operation, which might play an important role in maintaining vasocon- striction after the Fontan operation. AM functions in protective mechanism postoperatively.
出处 《中国心血管病研究》 CAS 2015年第1期75-78,95,共5页 Chinese Journal of Cardiovascular Research
基金 湖北省儿童先天性心脏病流行病学调查(项目编号:JX6B90) 中新合作课题(项目编号:1215c013)
关键词 FONTAN手术 内皮素-1 肾上腺髓质素 肺动脉高压 全肺阻力 Fontan operation Endothelin - 1 Adrenomedullin Pulmonary hypertension Total pulmonary resistance
  • 相关文献

参考文献16

  • 1Gewillig M, Brown SC, Eyskens B. The Fontan circulation: who controls cardiac output.'? Interact Cardiovasc Thorac Surg, 2010, 10 : 428-433.
  • 2郭少先,吕小东,刘迎龙,李守军,沈向东,杨九光,王旭.改良Fontan手术治疗复杂先天性心脏病[J].中国胸心血管外科临床杂志,2007,14(2):89-92. 被引量:10
  • 3阮鹏飞,刘锦纷.Fontan类手术的发展与演变[J].中华胸心血管外科杂志,2014,30(5):277-281. 被引量:3
  • 4Watanabe K, Nishikimi T, Takamuro M, et adrenomedullin in the regulation of Fontan al. Possible role of circulation: matureform of plasma adrenomedullin is extracted in the lung in patients with Fontan procedure. Regul Pept, 2007, 141 : 129-134.
  • 5尚小珂,邓晓娴,夏成,柳梅,周红梅,张长东,张刚成.选择性内皮素受体拮抗剂对大鼠心肌纤维化模型细胞因子表达的影响[J].中国心血管病研究,2013,11(12):986-990. 被引量:2
  • 6Reichetzeder C, Tsuprykov O, Hocher B, et al. Endothelin re- ceptor antagonists in clinical research-Lessons learned from pre- clinical and clinical kidney studies. Life Sci, 2014, Mar 4. [ Epub ahead of print ].
  • 7Ovaert C, Thijs D, Dewolf D, et al. The effect of bosentan in patients with a failing Fontan circulation. Cardiol Young, 2009,19 : 331-339.
  • 8Jordan I, Corniero P, Balaguer M, et al. Adrenomedullin is a useful biomarker for the prognosis of critically ill septic children. Biomark Med, 2014,8 : 1065-1072.
  • 9Pang L, Qi J, Gao Y, et al. Adrenomedullin alleviates pul- monary artery collagen accumulation in rats with pulmonary hy- pertension induced by high blood flow. Peptides,2014,54: 101- 107.
  • 10Gottsater M, Ford LB, Ostling G, et al. Adrenomedullin is a marker of carotid plaques and intima-media thickness as well as brachial pulse pressure. J Hypertens, 2013,31 : 1959-1965.

二级参考文献77

  • 1郑琼莉,祝炜,贾晶,毛莉娜,王超,李红兵.转化生长因子β_1与心血管疾病[J].中国心血管病研究,2006,4(7):550-551. 被引量:3
  • 2Tweddell JS,Litwin SB,Thomas JP Jr,et al.Recent advances in the surgical management of the single ventricle pediatric patient.Pediatr Clin North Am,1999,46(2):465-480.
  • 3Jonas RA.Indications and timing for the bidirectional Glenn shunt versus the fenestrated Fontan circulation.J Thorac Cardiovasc Surg,1994,108(3):522-524.
  • 4Jonas RA,Castaneda AR.Modified Fontan procedure:atrial buffle and systemic venous to pulmonary artery anastomotic techniques.J Card Surg,1988,3(2):91-96.
  • 5Tokunaga S,Kado H,Imoto Y,et al.Total cavopulmonary connection with an extracardiac conduit:experience with 100 patients.Ann Thorac Surg,2002,73(1):76-80.
  • 6Gupta A,Daggett C,Behera S,et al.Risk factors for persistent pleural effusions after the extracardiac Fontan procedure.J Thorac Cardiovasc Surg,2004,127(6):1664-1669.
  • 7Kuroczynski W,Kampmann C,Choi YH,et al.The Fontan operation:from intra-to extracardiac procedure.Cardiovasc Surg,2003,11(1):70-74.
  • 8Marino BS.Outcomes after the Fontan procedure.Curr Opin Pediatr,2002,14(5):620-626.
  • 9Lemler MS,Scott WA,Leonard SR,et al.Fenestration improves clinical outcome of the Fontan procedure:a prospective,randomized study.Circulation,2002,105 (2):207-212.
  • 10Thompson LD,Petrossian E,McElhinney DB,et al.Is it necessary to routinely fenestrate an extracardiac Fontan? J Am Coll Cardiol,1999,34(2):539-544.

共引文献21

同被引文献48

  • 1郭健,刘迎龙,吕小东.肺血减少型先天性心脏病肺血来源的探讨[J].中华胸心血管外科杂志,2005,21(3):182-183. 被引量:19
  • 2Diller GP, Giardini A, Dimopoulos K, et al. Predictors of mor- bidity and mortality in contemporary Fontan patients: results from a muhicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J, 2010,31 : 3073-3083.
  • 3Bowater SE, Weaver RA, Thome SA, et al. The safety and effects of bosentan in patients with a Fontan circulation. Congenit Heart Dis, 2012,7 : 243-249.
  • 4Oudiz R J, Galie N, Olschewski H, et al. Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension. J Am Coll Cardiol, 2009,54 : 1971-1981.
  • 5Gewillig M, Brown SC, Eyskens B, et al. The Fontan circulation: who controls cardiac output? Interact Cardiovasc Thorac Surg, 2010,10 : 428-433.
  • 6Mitchell MB, Campbell DN, Ivy D, et al. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg, 2004, 128:693-702.
  • 7Ishida H, Kogaki S, Ichimori H, et al. Overexpression of endothelin-1 and endothelin receptors in the pulmonary arteries of failed Fontan patients. Int J Cardiol, 2012,159 : 34-39.
  • 8Ovaert C, Thijs D, Dewolf D, et al. The effect of bosentan in patients with a failing Fontancirculation. Cardiol Young,2009,19 : 331-339.
  • 9Hirono K, Yoshimura N, Taguchi M, et al. Bosentan induces clinical and hemodynamic improvement incandidates for fight- sided heart bypass surgery. Congenital Heart Disease, 2010,140:346-351.
  • 10Fattinger K, Funk C, Pantze M, et al. The endothelin antago- nist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharma- col Ther, 2001,69 : 223-231.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部